Rheumatoid Arthritis Market is expected to increase from $56.6 billio Rheumatoid Arthritis Market 2020 | Page 6

4.3 Pipeline Distribution by Mechanism of Action 40
4.3.1 Cytokine Inhibitors 41
4.3.2 B- and T-cells 43
4.3.3 Intracellular kinases 44

5 Clinical Trial Analysis 45
5.1 Overall Attrition Rate 45
5.2 Attrition Rate by Phase, Molecule Type and Method of Administration 45
5.3 Average Clinical Trial Size by Molecule Type 48
5.4 Average Clinical Trial Size by Mechanism of Action 51
5.5 Average Clinical Trial Duration per Molecule Type by Product 53
Read Complete Report with TOC @ http://www.radiantinsights.com/research/rheumatoidarthritis-market-to-2020-a-crowded-market-characterized-by-modest-growth
5.6 Average Clinical Trial Duration per Mechanism of Action by Product 55
5.7 Primary and Secondary End Points 56
5.8 Summary 57
5.9 Promising Pipeline Drugs 57
5.9.1 Phase III Programs 57
5.9.2 Phase II Programs 64
5.10 Comparative Heat Map 66

6 Market Forecasts to 2020 69
6.1 Geographical Markets 69
6.2 Global Market 69
6.2.1 Treatment Usage Patterns 70
6.2.2 Market Size 71